![]()
|
|
||||||||
(Received for publication, December 2, 1994) We have constructed, expressed, and purified a fusion protein,
HAR-TX
Volume 270,
Number 13,
Issue of March 31, 1995 pp. 7625-7630
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
2, consisting of heregulin-
2 fused to a
binding-defective form of Pseudomonas exotoxin A, PE40. The
fusion protein was found to induce receptor tyrosine phosphorylation in
CEM cells transfected with HER4 alone or in combination with HER2 but
not in cells transfected with HER2 or HER1 alone. The phosphorylation
of receptor tyrosines was both dose-dependent and saturable in amounts
similar to those shown to be active for native heregulin. HAR-TX
2
was specifically cytotoxic toward a variety of carcinoma cell lines in
the ng/ml range. However, some tumor cell lines were found to be
insensitive to the cytotoxic action of the fusion protein even at >2
µg/ml. Relative amounts of HER4, HER3, and HER2 were determined on
seven cell lines sensitive and four cell lines insensitive to HAR-TX
2. All lines that express HER4 were killed by HAR-TX
2, while
none lacking HER4 were affected. HAR-TX
2 was able to bind to and
signal via tyrosine phosphorylation in cell lines that co-express HER2
and HER3 in the absence of HER4 without inducing cytotoxicity. Thus
HAR-TX
2 may prove to be a useful reagent for the targeting and
elimination of HER4-positive tumor cells.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Srinivasan, C. E. Gillett, D. M. Barnes, and W. J. Gullick Nuclear Expression of the c-erbB-4/HER-4 Growth Factor Receptor in Invasive Breast Cancers Cancer Res., March 1, 2000; 60(6): 1483 - 1487. [Abstract] [Full Text] |
||||
![]() |
R. Landgraf, D. Fischer, and D. Eisenberg Analysis of heregulin symmetry by weighted evolutionary tracing Protein Eng. Des. Sel., November 1, 1999; 12(11): 943 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Cohen, P. A. Kiener, J. M. Green, L. Foy, H. P. Fell, and K. Zhang The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells J. Biol. Chem., November 29, 1996; 271(48): 30897 - 30903. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Cohen, J. M. Green, L. Foy, and H. P. Fell HER4-mediated Biological and Biochemical Properties in NIH 3T3 Cells J. Biol. Chem., March 1, 1996; 271(9): 4813 - 4818. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Baulida, M. H. Kraus, M. Alimandi, P. P. Di Fiore, and G. Carpenter All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired J. Biol. Chem., March 1, 1996; 271(9): 5251 - 5257. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Bermingham-McDonogh, K. McCabe, and T. Reh Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina Development, January 5, 1996; 122(5): 1427 - 1438. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |